<i>Grb10</i> expression in diverse tumors suppresses proliferation. by Rana Mroue (743596)

Experimental design and model validation. by David J. Braun (7107692)

“…At 5 months of age, animals were fed a tamoxifen diet for 4 weeks, then transferred back to normal chow to allow for replenishment of p38α-expressing peripheral myeloid cells. …”

Table1_Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.DOCX by Guangyao Zhou (12704750)

“…Furthermore, Jag1 was demonstrated as a target of microRNA-26b-5p (miR-26b-5p). Interestingly, miR-26b-5p inhibitor prevented HSC activation inhibition caused by kaempferol. …”

Table2_Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.DOCX by Guangyao Zhou (12704750)

“…Furthermore, Jag1 was demonstrated as a target of microRNA-26b-5p (miR-26b-5p). Interestingly, miR-26b-5p inhibitor prevented HSC activation inhibition caused by kaempferol. …”

Shortened repression delay in repression r2 at the single-cell level for replicate experiment. by Lea Schuh (7144421)

“…<p>(A) Single-cell traces of total Gal1-GFP fluorescence signal across two inductions i1 and i2 (gray) and repressions r0, r1, and r2 (blue). …”

Image_1_Vitamin A Deficiency in the Early-Life Periods Alters a Diversity of the Colonic Mucosal Microbiota in Rats.TIF by Baolin Chen (8317047)

“…The results showed that the concentrations of serum retinol were > ~1.05 μmol/L in maternal VA normal (VAN)rats and < 0.7 μmol/L in maternal VAD rats, while the serum retinol levels were higher than 0.7 μmol/L in the pups of the VAN group and below 0.5 μmol/L in the pups of the VAD group. Compared to the offspring persistent with VAN from embryonic stage (group A), all the remaining groups exhibited an increased ratio of Firmicutes/Bacteroidetes abundance. …”

Comparison of the Predictive Values of CKD in Each Surrogate Maker of Obesity. by Keiichi Odagiri (522165)

Effects of Met concentrations 250μM-1mM on MYH1/2, Myf5, p21 and PGC-1α expression in myotubes. by Eleonora Maniscalco (14599854)

“…Met reduces MYH1/2 protein expression starting from 400μM, with a more evident decrease at 800μM and 1mM. The expression levels of Myf5 decreases after 400μM Met treatment and increases at higher concentrations especially at 800μM. …”

Additional file 2 of Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients by Paula L. Scalzo (20882386)

Spontaneous Recurrence of Deposition and Dissolution of a Solid Layer on a Solution Surface by Tomohiro Sasaki (1375869)

Spontaneous Recurrence of Deposition and Dissolution of a Solid Layer on a Solution Surface by Tomohiro Sasaki (1375869)

<i>col27a1a</i> is required for notochord development. by Helena E. Christiansen (368143)

“…Dorsal (D) and lateral (F) views of <i>col27a1a</i> morphants at ∼5.6 SSL (14 dpf) show formation of notochord curves at the distal end of the tail. …”

(A) Kank inhibits active RhoA through 14-3-3 by Naoto Kakinuma (46267)

“…(C and D) GFP-Kank but not GFP-Kank inhibits insulin-dependent RhoA activation. We generated tetracycline-inducible stable cells expressing GFP-Kank (lanes 1–4) or GFP-Kank (lanes 5–8) using NIH3T3 cells and tested the levels of active RhoA in these cells with (lanes 2, 4, 6, and 8) or without (lanes 1, 3, 5, and 7) insulin stimulation. …”

Incidence of CKD in Relation to Quartiles of Waist to height ratio (WheiR) Stratified by Gender. by Keiichi Odagiri (522165)

Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Crystal Structure of YbCu₆In₆ and Mixed Valence Behavior of Yb in YbCu_6–<i>x</i>In_6+<i>x</i> (<i>x</i> = 0, 1, and 2) Solid Solution by Udumula Subbarao (1431364)

“…YbCu₆In₆ crystallizes in the CeMn₄Al₈ structure type, tetragonal space group <i>I</i>4/<i>mmm</i>, and the lattice constants are <i>a</i> = <i>b</i> = 9.2200(13) Å and <i>c</i> = 5.3976(11) Å. …”

Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”

Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”